Pure Global AI
NCT06401148Not yet recruiting

Exercise-based Cardiac Rehabilitation for Atrial Fibrillation

Exercise-based Cardiac Rehabilitation for Patients With Atrial Fibrillation Receiving Catheter Ablation
Liverpool John Moores UniversityClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Atrial Fibrillation
Drug/Device/Intervention
Cardiac rehab intervention group
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Liverpool John Moores University
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Dec 01, 2025
Enrollment
80 participants
Primary outcome

Number of patients screened, eligible and approached,Patient focus groups to assess intervention and testing acceptability,Clinical exercise physiologist interview to assess intervention and testing acceptability

Summary

The investigators aim to conduct a pilot randomised controlled trial (RCT) with embedded
 feasibility study to evaluate an exercise-based cardiac rehabilitation (ExCR) programme when
 delivered to patients with atrial fibrillation on the waiting list for catheter ablation. Our
 overall objective is to test the feasibility and acceptability of an evidence-based ExCR
 intervention prior to evaluation in a future randomized controlled trial (RCT).

ICD-10 classifications
Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06401148
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06401148 through Pure Global AI's free database. This phase not specified trial is sponsored by Liverpool John Moores University and is currently Not yet recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.